Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

MRI Superficial Temporal Artery

This study has been completed.
Information provided by:
University Health Network, Toronto Identifier:
First received: September 12, 2005
Last updated: April 20, 2007
Last verified: September 2005
Repeat MRI of the Superficial temporal Artery in 5 volunteers

Condition Intervention Phase
Temporal Arteritis
Device: MRI
Phase 1

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: MRI of the Superficial Temporal Artery

Resource links provided by NLM:

Further study details as provided by University Health Network, Toronto:

Primary Outcome Measures:
  • Accuracy in displaying the superfifical temporal artery

Estimated Enrollment: 5
Study Start Date: April 2003
Estimated Study Completion Date: April 2004
Detailed Description:
Repeat MRI of the Superficial temporal Artery in 5 volunteers

Ages Eligible for Study:   16 Years and older   (Child, Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • controls with normal temporal arteries

Exclusion Criteria:

  • contraindication to MR
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00188448

Canada, Ontario
Toronto General Hospital
Toronto, Ontario, Canada
Sponsors and Collaborators
University Health Network, Toronto
Principal Investigator: Narinder Paul, FRCP C University Health Network, Toronto
  More Information Identifier: NCT00188448     History of Changes
Other Study ID Numbers: 03-0223 
Study First Received: September 12, 2005
Last Updated: April 20, 2007
Health Authority: Canada: Health Canada

Additional relevant MeSH terms:
Giant Cell Arteritis
Vascular Diseases
Cardiovascular Diseases
Vasculitis, Central Nervous System
Autoimmune Diseases of the Nervous System
Nervous System Diseases
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Skin Diseases, Vascular
Skin Diseases
Autoimmune Diseases
Immune System Diseases processed this record on October 21, 2016